agonista glp 1 GLP1 Receptor Agonists—Effects beyond Obesity and Diabetes Glucagon-like peptide-1 - Wikipedia

For example, prescribing data for one oral GLP-1 tablet reported that among patients who had gastrointestinal side effects, 60% were mild, 36% were moderate and 4% were severe

12 Furthermore, GLP-1RAs reduce the secretion of proinflammatory cytokines, namely interleukin 6 (IL-6) and tumor necrosis factor alpha (TNF-), which are often elevated in neuroinflammatory conditions like migraine

The clinical research and emerging data on tirzepatide-based compounds, including GLP-1 GIP B12 formulations, point to a range of metabolic, cardiovascular, and anti-inflammatory benefits that extend well beyond the number on the scale

2024;16:eadk4908

MPR, medication possession rate

We address this knowledge gap by examining the impact of GLP-1RA initiation on the risk of new-onset AF/Aflutter and stroke among patients with T2D who continuously received levothyroxine therapy